Is hypokalaemia the cause of paralysis in barium poisoning?
Soluble salts of barium, commonly used industrially, are highly toxic. Weakness and hypokalaemia are the characteristic signs of barium poisoning. Reports have suggested that the weakness is due to hypokalaemia and that potassium is the antidote.1 2 We describe a patient poisoned by barium in whom the degree of weakness correlated with plasma barium concentrations and not potassium concentrations.
Case report
A 39 year old art teacher attempted suicide by ingesting 40 g barium carbonate, normally used for glazing pottery. She developed colicky abdominal pain, diarrhoea, and vomiting and was admitted to hospital 10 hours after ingestion. On examination she had generalised muscle weakness with active movement against gravity (grade III on the Medical Research Council's grading of muscle power). Her plasma potassium concentration was 1-5 mmol(mEq)/l. After gastric lavage she received sodium sulphate 60 g through a nasogastric tube and magnesium sulphate 2-5 g intravenously. Hypokalaemia was treated with intravenous potassium, 254 mmol in the first three days (see figure) .
The muscle weakness increased, and 17 hours after ingestion she required mechanical ventilation for respiratory failure. In the next six hours she developed complete flaccid paralysis, which was generalised apart from minimal residual voluntary movement of the eye and eyelid. One day later flickers of muscle activity and weak spontaneous breathing returned. Her vital capacity and cough were adequate to permit extubation four and a half days after ingestion. She had regained normal power a week later. Despite a normal haemodynamic state, from day 2 she showed progressive oliguric renal insufficiency, and three days later her plasma creatinine concentration peaked at 300 /.Lmol/l (3 4 mg/100 ml) (normal 50-1200 4mol/l (0-6-13-6 mg/100 ml)). This resolved within six days.
The figure shows serial plasma barium concentrations (measured by inductively coupled plasma emission spectroscopy), plasma potassium concentrations, and the degree of muscle weakness. Serum magnesium concentration was above normal at 1-3 mmol/l (3-2 mg/100 ml). Electrodiagnostic investigations during the period of flaccid paralysis showed the muscle to be electrically silent and unexcitable. Nerve action potentials were elicited in sensory and mixed peripheral nerves. In the early stages of recovery low amplitude, short duration "myopathic" units were evident and motor conduction velocity was normal. Investigation of peripheral nerve stimulation (using a Myograph 2000) showed no evidence of competitive (non-depolarising) neuromuscular blockade. Biopsy of the vastus medialis muscle showed normal sarcolemmal nuclei, sarcoplasm, and interstitial tissues. Mild and non-specific atrophy (type IIb) was detected on quantitative histochemical examination. The changes characteristic of hypokalaemic paralysis were not present. 3 
Comment
Barium initiates or potentiates synaptic transmission, probably by causing release of acetylcholine.4 Any ensuing neuromuscular blockade would be expected to be depolarising in nature. Barium also competitively reduces the permeability of cell membranes to potassium, which, again, may lead to membrane depolarisation. 2 The electrodiagnostic investigation showed that nerve conduction was normal, which suggested that the adverse physiological changes had occurred either in the muscle or at the neuromuscular junction. As the muscle biopsy specimen showed mild and non-specific change the weakness may have been caused primarily by neuromuscular blockade, which, the results of the investigation of nerve stimulation suggested, was probably depolarising in nature. Barium: 1 pmol/l 5-6 jug/100 ml.
As barium has a depolarising effect on membranes, and as we saw a close correlation between the serial barium concentrations in the patient and the intensity of neuromuscular blockade, we suggest that barium was the direct cause of the muscle weakness. There was no correlation between plasma potassium concentrations and the degree of weakness. The renal insufficiency in this patient may have been due to precipitation of barium sulphate in renal tubules,5 which suggests that intravenous sulphate-for example, magnesium sulphate-should be avoided in the treatment of barium poisoning.
